Blue Sail Medical Co.,Ltd. (SHE:002382)
China · Delayed Price · Currency is CNY 5.88
+0.07 (1.20%)
At close: Feb 13, 2026
Blue Sail Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 5,704 | 6,177 | 4,850 | 4,834 | 8,064 | 7,824 |
Other Revenue | 76.37 | 76.37 | 76.73 | 66.18 | 44.59 | 45.49 |
| 5,781 | 6,253 | 4,927 | 4,900 | 8,109 | 7,869 | |
Revenue Growth (YoY) | -3.61% | 26.91% | 0.54% | -39.56% | 3.04% | 126.42% |
Cost of Revenue | 5,017 | 5,262 | 4,393 | 4,481 | 4,382 | 2,814 |
Gross Profit | 763.26 | 991.03 | 533.82 | 419.17 | 3,726 | 5,056 |
Selling, General & Admin | 805.23 | 814.49 | 788.43 | 701.86 | 765.15 | 681.17 |
Research & Development | 289.19 | 341.92 | 290.75 | 352.49 | 438.52 | 291.44 |
Other Operating Expenses | 62.09 | 33.18 | 27.56 | 36.92 | 54.78 | 34.39 |
Operating Expenses | 1,172 | 1,212 | 1,125 | 1,093 | 1,279 | 1,053 |
Operating Income | -408.43 | -221.29 | -591.62 | -674.02 | 2,448 | 4,003 |
Interest Expense | -278.53 | -278.98 | -180.47 | -129.48 | -133.32 | -189.92 |
Interest & Investment Income | 43.31 | 30.38 | 40.67 | 294.44 | 81.06 | 100.11 |
Currency Exchange Gain (Loss) | 53.09 | 53.09 | 33.88 | 62.8 | -86.36 | -149.76 |
Other Non Operating Income (Expenses) | 4.01 | -5.72 | -6.69 | -12.26 | -27.4 | -4.25 |
EBT Excluding Unusual Items | -586.54 | -422.51 | -704.23 | -458.51 | 2,282 | 3,759 |
Impairment of Goodwill | - | - | - | - | -1,698 | -1,755 |
Gain (Loss) on Sale of Investments | 3.23 | -11.1 | 70.63 | -6.74 | 1,098 | 1.06 |
Gain (Loss) on Sale of Assets | -0.89 | -0.84 | -1.92 | 0.07 | -1.89 | 3.95 |
Asset Writedown | -36.12 | -6.29 | -21.47 | -6.94 | -370.68 | -19.87 |
Other Unusual Items | 85.35 | 39.14 | 34.38 | 66.26 | 38.08 | 29.04 |
Pretax Income | -534.97 | -401.6 | -622.61 | -405.86 | 1,347 | 2,018 |
Income Tax Expense | 5.72 | 63.32 | -54.25 | -33.54 | 191.65 | 255.34 |
Earnings From Continuing Operations | -540.69 | -464.92 | -568.36 | -372.32 | 1,156 | 1,763 |
Minority Interest in Earnings | 28.95 | 19.31 | - | 0 | 0 | -4.57 |
Net Income | -511.75 | -445.61 | -568.36 | -372.32 | 1,156 | 1,758 |
Net Income to Common | -511.75 | -445.61 | -568.36 | -372.32 | 1,156 | 1,758 |
Net Income Growth | - | - | - | - | -34.28% | 258.66% |
Shares Outstanding (Basic) | 1,029 | 1,013 | 1,015 | 1,006 | 1,023 | 966 |
Shares Outstanding (Diluted) | 1,029 | 1,013 | 1,015 | 1,006 | 1,051 | 1,016 |
Shares Change (YoY) | 2.70% | -0.21% | 0.86% | -4.22% | 3.36% | 5.73% |
EPS (Basic) | -0.50 | -0.44 | -0.56 | -0.37 | 1.13 | 1.82 |
EPS (Diluted) | -0.50 | -0.44 | -0.56 | -0.37 | 1.10 | 1.73 |
EPS Growth | - | - | - | - | -36.42% | 239.22% |
Free Cash Flow | -199.86 | -638.43 | -847.03 | -402.39 | -336.22 | 2,468 |
Free Cash Flow Per Share | -0.19 | -0.63 | -0.83 | -0.40 | -0.32 | 2.43 |
Dividend Per Share | - | - | - | 0.400 | - | 0.400 |
Dividend Growth | - | - | - | - | - | 300.00% |
Gross Margin | 13.20% | 15.85% | 10.83% | 8.55% | 45.96% | 64.25% |
Operating Margin | -7.07% | -3.54% | -12.01% | -13.75% | 30.19% | 50.87% |
Profit Margin | -8.85% | -7.13% | -11.54% | -7.60% | 14.25% | 22.35% |
Free Cash Flow Margin | -3.46% | -10.21% | -17.19% | -8.21% | -4.15% | 31.37% |
EBITDA | 105.13 | 289.58 | -84.34 | -200.95 | 2,765 | 4,217 |
EBITDA Margin | 1.82% | 4.63% | -1.71% | -4.10% | 34.10% | 53.58% |
D&A For EBITDA | 513.56 | 510.87 | 507.27 | 473.06 | 317.51 | 213.71 |
EBIT | -408.43 | -221.29 | -591.62 | -674.02 | 2,448 | 4,003 |
EBIT Margin | -7.07% | -3.54% | -12.01% | -13.75% | 30.19% | 50.87% |
Effective Tax Rate | - | - | - | - | 14.22% | 12.65% |
Revenue as Reported | 5,781 | 6,253 | 4,927 | 4,900 | 8,109 | 7,869 |
Advertising Expenses | - | 80.29 | 88.32 | 54.61 | 24.98 | 115.52 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.